We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Allows Emergency Use of Anti-Malaria Drugs for COVID-19 Treatment
FDA Allows Emergency Use of Anti-Malaria Drugs for COVID-19 Treatment
The FDA issued an emergency use authorization (EUA) for the anti-malaria drugs hydroxychloroquine sulfate and chloroquine phosphate, clearing the way for HHS to distribute millions of doses for COVID-19 patients.